[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367573-105":59,"doc-detail-367573-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-comprehensive-analysis-of-the-role-of-dsn1-in-pan-cancer-prognosis-and-immunotherapy","A Comprehensive Analysis of the Role of DSN1 in Pan-Cancer Prognosis and Immunotherapy","","Background: Dosage Suppressor of NNF1 (DSN1) is a component of the MIS12 kinetochore complex essential for cell-cycle progression, with growing evidence linking it to cancer progression. Methods: Public databases were used to assess DSN1 expression across cancers using mRNA, protein, and single-cell sequencing data. Survival analysis evaluated prognostic associations, while mutation frequencies and gene set enrichment identified related pathways. Results: DSN1 was overexpressed in tumor and dividing cells, with cancer-type-dependent prognostic effects. DSN1-high tumors showed higher mutation/amplification frequencies in cancers such as COAD, LUAD, and UCEC, enrichment of cell-cycle pathways, and positive correlations with DNA methylation, TMB, MSI, immune infiltration, immune-regulatory genes, immunotherapy response, and drug sensitivity. Conclusion: DSN1 is important for tumorigenesis, progression, and immunotherapy across multiple cancer types.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comprehensive-analysis-of-the-role-of-dsn1-in-pan-cancer-prognosis-and-immunotherapy/367573/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comprehensive-analysis-of-the-role-of-dsn1-in-pan-cancer-prognosis-and-immunotherapy/367573.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is DSN1 and why is it relevant to cancer?","Question",{"text":113,"@type":114},"DSN1 (Dosage Suppressor of NNF1) is part of the MIS12 kinetochore complex required for cell-cycle progression. The study motivates its relevance because DSN1 is linked to cancer progression and biology.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study evaluate DSN1 across different cancer types?",{"text":118,"@type":114},"It used public databases to examine DSN1 expression patterns using mRNA, protein, and single-cell sequencing data. It then assessed prognostic associations with survival analysis and compared mutation frequencies between DSN1-high and DSN1-low groups.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationships did the researchers find between DSN1 and tumor immunity or immunotherapy?",{"text":122,"@type":114},"DSN1 expression was closely associated with tumor-infiltrating immune cells and immune-regulatory genes. It also showed links to immune therapy response and drug sensitivity, alongside correlations with DNA methylation, TMB, and MSI in most cancers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367573,1790794616,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2025; 16(8): 2449-2465. doi: 10.7150/jca.111585  \nResearch Paper  \nA Comprehensive Analysis of the Ro le of DSN1 in Pan-Cancer Prognosis and Immunotherapy  \nDonggang Xu1, Yue Zhang1, Maoqia Shen1, Xiaolong Cao2,3􀀍  \n1. Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, Guangdong, China.  \n2. Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, Guangdong, China.  \n3. Translational Medicine Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, Guangdong, China.  \n􀀍 Corresponding author: Xiaolong Cao; Email: [atps@smu.edu.cn](atps@smu.edu.cn); Tel.: 86-17665132073.  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.02.05; Accepted: 2025.03.30; Published: 2025.04.21  \nAbstract  \nBackground: Dosage Suppressor of NNF1 (DSN1) is a component of the MIS12 kinetochore complex crucial in the cell cycle process. Recent evidence indicates its close association with cancer progression. The study aims to further explore DSN1’s role in cancer.  \nMethods: Using public databases, we investigated the expression patterns of DSN1 in mRNA, protein, and single-cell sequencing data across cancer types. Prognostic associations were assessed through survival analysis, and gene mutation frequencies were compared between high and low DSN1 expression groups. Gene set enrichment analysis was conducted to identify relevant biological pathways. We also examined the correlation of DSN1 with DNA methylation, tumor mutation burden (TMB), microsatellite instability (MSI), immune infiltration, and immune-regulatory genes.  \nResults: Our analysis revealed that DSN1 is consistently overexpressed in tumor cells and actively dividing cells compared to normal tissues. The overexpression of DSN1 showed a significant correlation with either poor or favorable prognosis, depending on the cancer type. Notably, cancers such as COAD, LUAD, and UCEC exhibited high mutation and amplification frequencies in the DSN1-high group. Gene set enrichment analysis identified cell cycle-related pathways as the most significantly associated with DSN1 expression. Furthermore, DSN1 expression was positively correlated with DNA methylation, TMB, and MSI in most cancers. DSN1 was also closely associated with tumor-infiltrating immune cells and immune-regulatory genes, as well as immune therapy response and drug sensitivity.  \nConclusion: Our findings highlight the importance of DSN1 in tumorigenesis, progression, and immune therapy across various cancer types. Further studies are needed to explore its specific applications in individual cancer types.  \nKeywords: DSN1, pan-cancer, biomarker, prognosis, immunotherapy.  \nIntroduction  \nDespite decades of research and advancementsin cancer care, its impact on global health remains profound, underscoring the urgent need for innovative therapeutic strategies. Globally, approximately 20 million individuals were newly diagnosed with cancer in 2022, resulting in 9.7 million deaths to tumor-related causes [1] . Therefore, it is imperative to develop new therapeutic approaches,  \nwith a focus on immunotherapies that leverage tumor biomarkers, to improve patient outcomes [2] .  \nThe Dosage Suppressor of NNF1 (DSN1) is a protein in MIS12 kinetochore complex, essential forkinetochore assembly and cell cycle progression. It ensures the accurate transmission of genetic material by facilitating proper chromosome segregation. Consequently, dysfunction of DSN1 can lead to  \ngenomic instability, a favorable condition for tumorigenesis [3,4] . While DSN1 is predominantly studied in cancer, emerging evidence suggests its ","cbCaib2Cc44WZQdr","https://ap.wps.com/l/cbCaib2Cc44WZQdr","pdf",14681448,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and Methods","[{\"question\":\"What is DSN1 and why is it relevant to cancer?\",\"answer\":\"DSN1 (Dosage Suppressor of NNF1) is part of the MIS12 kinetochore complex required for cell-cycle progression. The study motivates its relevance because DSN1 is linked to cancer progression and biology.\"},{\"question\":\"How did the study evaluate DSN1 across different cancer types?\",\"answer\":\"It used public databases to examine DSN1 expression patterns using mRNA, protein, and single-cell sequencing data. It then assessed prognostic associations with survival analysis and compared mutation frequencies between DSN1-high and DSN1-low groups.\"},{\"question\":\"What relationships did the researchers find between DSN1 and tumor immunity or immunotherapy?\",\"answer\":\"DSN1 expression was closely associated with tumor-infiltrating immune cells and immune-regulatory genes. It also showed links to immune therapy response and drug sensitivity, alongside correlations with DNA methylation, TMB, and MSI in most cancers.\"}]","A Comprehensive Analysis of the Role of DSN1 in Pan-Cancer Prognosis and Immunotherapy | PDF",1790171428,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e20a3bf0ec2e0ad7692dc348ebc59b2.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/039153c6759f5c86f5e3d5c2c469b009.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe1fe155adfb1f2cc9c052a2bf2f8b7d.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/051e79c3ebb6af5b71102eafc810c0fb.webp",980,1268]